“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...

Dividend stocks have historically outperformed non-dividend payers. Dividend stocks can make great long-term investments.

Historically, Johnson & Johnson has been a fairly stable stock to own. Johnson & Johnson (NYSE: JNJ) has been a leading ...

Key Points The investment advisor sold 38,037 shares for a total of $6.31 million in Q2 2025.Move removes JNJ from portfolio, freeing capital for other top holdings.As much as 5.1% of Andrew Hill's ...

Kenvue is spending big to drum up demand for its diversified product portfolio. The company's weak results reflect pressure ...

Analysts expect Johnson & Johnson to report an earnings per share (EPS) of $2.67. Johnson & Johnson bulls will hope to hear ...

Vista’s U.S. Quality Premier strategy returned +14.29% net-of-fees in the second quarter of 2025. Read more here.

Real-time index price for TSX Composite Dividend Index (TXDC), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Real-time index price for TSX Canadian Dividend Aristocrats Index (TXDV), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Telos Capital Management reduced its Johnson & Johnson stake by nearly 11% last quarter, selling 5,837 shares worth over $8 ...